Delivery Order SPE2DB22D1002-SPE2DB25FLFG7
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,027.70 for Ingrezza 80 mg capsules (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ingrezza is a prescription medication used to treat tardive dyskinesia, a movement disorder, and represents...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,049.61 for INGREZZA 60 mg capsules (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $7,352.24 delivery order contract is for the supply of Ingrezza 40 mg capsules, a medication used to treat neurological conditions. The contract has a firm fixed price and an ultimate completion date of May 28, 2025. This award is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- The Defense Logistics Agency Troop Support Medical awarded a $3,119.55 delivery order to Amerisourcebergen Drug Corporation for 40mg capsules of Ingrezza. The firm fixed price order is for 30 capsules to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania between August 8 and 29, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, this order for a central nervous system drug supports the Agency's mission to provide quality...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,027.70 firm fixed-price contract is for the supply of the medication Ingrezza 80 mg capsules. The order has an ultimate completion date of January 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,119.55 firm fixed-price delivery order is for the supply of Ingrezza 40 mg capsules with a completion date of June 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,099.22 firm fixed-price delivery order contract is for the supply of 60 mg Ingrezza capsules. Ingrezza is a specialty medication used to treat a neurological disorder. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- The Defense Logistics Agency awarded a $6,239.10 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40mg capsules of Ingrezza. Under the contract, Amerisourcebergen will deliver 30 capsules of the specified medication to a facility in Conshohocken, Pennsylvania, with performance taking place between September 21, 2023 and October 13, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. No subcontractors or set...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,245,535 units of the medication INGREZZA 80 MG CAPSULE 30S. The fixed-price delivery order has a ceiling value of $4,027.70 and a completion date of June 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563920336 - INGREZZA 80 MG CAPSULE 30S. This $3,893.15 order, awarded on March 11, 2024, has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is the sole awardee on this delivery order, which is not associated with any set-aside designation. Amerisourcebergen Drug...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLFG7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed price contract valued at $4,027.70, with an ultimate completion date of August 15, 2025. This non-competitive delivery order was issued on July 25, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a child order under the company's larger indefinite delivery contract vehicle with DLA Troop Support Medical. This delivery order falls under AmerisourceBergen Drug Corp's $999.999 billion Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Ingrezza, an antipsychotic medication used in treating tardive dyskinesia, represents one of the specialized pharmaceutical products the company delivers through its federal contract portfolio to support military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 7/25/25 |